Cargando…
Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria
BACKGROUND: The Plasmodium falciparum chimeric protein PfCP-2.9 is a promising asexual-stage malaria vaccine evaluated in clinical trials. This chimeric protein consists of two cysteine-rich domains: domain III of the apical membrane antigen 1 (AMA-1 [III]) and the C-terminal region of the merozoite...
Autores principales: | Peng, Heng, Hu, Yunfei, Zhou, Aiguo, Jin, Changwen, Pan, Weiqing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850360/ https://www.ncbi.nlm.nih.gov/pubmed/20236549 http://dx.doi.org/10.1186/1475-2875-9-76 |
Ejemplares similares
-
Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum
por: Li, Changling, et al.
Publicado: (2010) -
Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
por: Hu, Jinhong, et al.
Publicado: (2008) -
Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-3(11) and MSP-1(19): PfAMSP-Fu(35)
por: Kalra, Aakanksha, et al.
Publicado: (2016) -
The N-Terminal Region of Plasmodium falciparum MSP10 Is a Target of Protective Antibodies in Malaria and Is Important for PfGAMA/PfMSP10 Interaction
por: Nagaoka, Hikaru, et al.
Publicado: (2019) -
Evolution of Genetic Polymorphisms of Plasmodium falciparum Merozoite Surface Protein (PfMSP) in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2014)